Hugh Smisson
Internal Medicine · Macon, GANPI 1285120766
Payments from drug & device makers
Across 53 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$212
- AstraZeneca$109
- Amgen$100
- E.r. Squibb & Sons, L.L.C.$69
- Melinta Therapeutics, LLC$65
- Bayer$63
- plus $468 from 19 others
What the payments were for
- Food & beverage$1,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $212 |
| AstraZeneca(2 entities) | 6 | $109 |
| Amgen | 6 | $100 |
| E.r. Squibb & Sons, L.L.C. | 5 | $69 |
| Melinta Therapeutics, LLC | 4 | $65 |
| Bayer | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Pfizer | 3 | $49 |
| Ardelyx, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| GSK | 2 | $28 |
| Eisai Inc. | 2 | $28 |
| Vertex | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Intrinsic Therapeutics | 1 | $17 |
| Abbott | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$125
How this compares
$1,087 in reported general payments places this provider in the 65th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $202 |
| Atorvastatin Calcium | 21 | $118 |
| Amlodipine Besylate | 14 | $59 |
| Hydrochlorothiazide | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Macon
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.